BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
15.08
-0.48 (-3.08%)
At close: Oct 10, 2025, 4:00 PM EDT
14.85
-0.23 (-1.53%)
After-hours: Oct 10, 2025, 7:45 PM EDT
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $301.99 million as of October 10, 2025. Its market cap has increased by 131.88% in one year.
Market Cap
301.99M
Enterprise Value
227.84M
1-Year Change
131.88%
Ranking
Category
Stock Price
$15.08
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $301.99M, an increase of 68.78%. That is a compound annual growth rate of 4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 301.99M | 67.43% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | 79.04M | -26.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |